Sanofi (France)’s Sleep Driving Drug Should Remain on the Shelves Says Australian Therapeutic Goods Administration

An insomnia treatment linked to sleepwalking and sleep driving should stay on the market according to the Australian Therapeutic Good Administration (TGA).
Read the full story: BioSpace.com Featured News